Back to Journals » OncoTargets and Therapy » Volume 8 » Treatment compliance and severe adverse events limit the use of tyrosine kinase inhibitors in refractory thyroid cancer
Please verify you are not a robot.
Back to Journals » OncoTargets and Therapy » Volume 8 » Treatment compliance and severe adverse events limit the use of tyrosine kinase inhibitors in refractory thyroid cancer
Please verify you are not a robot.